IFNG and cancer: Optimized NP formulations delivering 4-1BBL/IL-12or 4-1BBL/IL-12/IFNγ DNA successfully transfect MCC and melanomacells in vitro and in vivo, respectively,resulting in IFNγ-driven upregulation of MHC class I and IImolecules on cancer cells.